SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-17-009849
Filing Date
2017-09-20
Accepted
2017-09-20 11:25:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G sc13g0917a2alpha_oxisinter.htm SC 13G/A 36726
  Complete submission text file 0001213900-17-009849.txt   38613
Mailing Address 100 SOUTH ASHLEY DRIVE SUITE 600 TAMPA FL 33602
Business Address 100 SOUTH ASHLEY DRIVE SUITE 600 TAMPA FL 33602 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-32837 | Film No.: 171093525
SIC: 2834 Pharmaceutical Preparations

Mailing Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999
Business Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999 0114232376363
ALPHA CAPITAL ANSTALT (Filed by) CIK: 0001140358 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A